BNP Paribas Financial Markets’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $222K | Sell |
38,903
-21,445
| -36% | -$92.7K | ﹤0.01% | 4183 |
|
|
2026
Q1 | $234K | Buy |
60,348
+40,191
| +199% | +$165K | ﹤0.01% | 3976 |
|
|
2025
Q4 | $84.3K | Sell |
20,157
-31,639
| -61% | -$122K | ﹤0.01% | 4450 |
|
|
2025
Q3 | $170K | Buy |
51,796
+2,993
| +6% | +$8.45K | ﹤0.01% | 4081 |
|
|
2025
Q2 | $69.3K | Buy |
48,803
+28,005
| +135% | +$39.8K | ﹤0.01% | 4140 |
|
|
2025
Q1 | $31K | Sell |
20,798
-3,553
| -15% | -$5.59K | ﹤0.01% | 4426 |
|
|
2024
Q4 | $27.3K | Buy |
+24,351
| New | +$20.8K | ﹤0.01% | 4640 |
|
|
2020
Q1 | – | Sell |
-22,683
| Closed | -$124K | – | 4426 |
|
|
2019
Q4 | $124K | Sell |
22,683
-66,225
| -74% | -$373K | ﹤0.01% | 3186 |
|
|
2019
Q3 | $509K | Buy |
88,908
+12,488
| +16% | +$84.9K | ﹤0.01% | 2197 |
|
|
2019
Q2 | $585K | Sell |
76,420
-19,990
| -21% | -$108K | ﹤0.01% | 1931 |
|
|
2019
Q1 | $507K | Buy |
96,410
+44,114
| +84% | +$306K | ﹤0.01% | 2095 |
|
|
2018
Q4 | $342K | Sell |
52,296
-3,958
| -7% | -$44.4K | ﹤0.01% | 1928 |
|
|
2018
Q3 | $969K | Buy |
56,254
+13,127
| +30% | +$195K | ﹤0.01% | 1765 |
|
|
2018
Q2 | $601K | Sell |
43,127
-10,868
| -20% | -$184K | ﹤0.01% | 1927 |
|
|
2018
Q1 | $828K | Buy |
53,995
+16,000
| +42% | +$229K | ﹤0.01% | 1873 |
|
|
2017
Q4 | $438K | Buy |
37,995
+9,404
| +33% | +$140K | ﹤0.01% | 2547 |
|
|
2017
Q3 | $544K | Sell |
28,591
-2,586
| -8% | -$53.2K | ﹤0.01% | 1941 |
|
|
2017
Q2 | $751K | Buy |
31,177
+6,937
| +29% | +$152K | ﹤0.01% | 1683 |
|
|
2017
Q1 | $480K | Buy |
24,240
+3,212
| +15% | +$71.7K | ﹤0.01% | 1759 |
|
|
2016
Q4 | $506K | Buy |
21,028
+19,192
| +1,045% | +$534K | ﹤0.01% | 1692 |
|
|
2016
Q3 | $51K | Buy |
1,836
+575
| +46% | +$15.2K | ﹤0.01% | 2424 |
|
|
2016
Q2 | $30.8K | Buy |
1,261
+447
| +55% | +$12.7K | ﹤0.01% | 2445 |
|
|
2016
Q1 | $27.3K | Sell |
814
-784
| -49% | -$24.7K | ﹤0.01% | 2120 |
|
|
2015
Q4 | $47.8K | Buy |
1,598
+1,260
| +373% | +$42.5K | ﹤0.01% | 2839 |
|
|
2015
Q3 | $10.7K | Sell |
338
-656
| -66% | -$32K | ﹤0.01% | 3419 |
|
|
2015
Q2 | $48.1K | Buy |
994
+152
| +18% | +$6.41K | ﹤0.01% | 2516 |
|
|
2015
Q1 | $36.5K | Buy |
+842
| New | +$30.3K | ﹤0.01% | 2078 |
|
|
2014
Q4 | – | Sell |
-2,219
| Closed | -$39.4K | – | 2877 |
|
|
2014
Q3 | $39.4K | Sell |
2,219
-4,372
| -66% | -$89.3K | ﹤0.01% | 2728 |
|
|
2014
Q2 | $158K | Buy |
6,591
+803
| +14% | +$16.3K | ﹤0.01% | 1871 |
|
|
2014
Q1 | $104K | Buy |
5,788
+5,624
| +3,429% | +$156K | ﹤0.01% | 1956 |
|
|
2013
Q4 | $3.74K | Buy |
+164
| New | +$3.31K | ﹤0.01% | 3297 |
|
Other funds holding PGEN
PCM
BCM
IAM
BNP Paribas Financial Markets's PGEN Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Precigen (PGEN) stake by 36% in Q2 2026, selling an estimated $92.7K and leaving 38,903 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #4183.
BNP Paribas Financial Markets first reported a position in PGEN in Q4 2013 and has held it in 31 quarters since. The position peaked at $969K in Q3 2018. 197 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- BNP Paribas Financial Markets held 38,903 shares of Precigen worth $222K as of Q2 2026.
- BNP Paribas Financial Markets sold 21,445 Precigen shares in Q2 2026, an estimated $92.7K.
- Precigen made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4183 holding.
- BNP Paribas Financial Markets first reported a position in Precigen in Q4 2013 and has held it in 31 quarters since.
- BNP Paribas Financial Markets's Precigen position peaked at $969K in Q3 2018.
- 197 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.